Evidence map›Paper›PMID 40337168›Full record

ArticleFrontiers in neurology2025

Eye movement and pupillary response abnormalities measured using virtual reality as biomarkers in the diagnosis of early-stage Parkinson's disease.

Jing Zhao, Chong Shi, Xucheng Zhang, Shaochen Ma, Wei Sun, Feng Tian, Peifu Wang, Jilai Li, Jichen Du, Xingquan Zhao and 1 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing ZhaoDepartment of Neurology, Aerospace Center Hospital, Beijing, China.
Chong ShiDepartment of Traditional Chinese Medicine, Aerospace Center Hospital, Beijing, China.
Xucheng ZhangInstitute of Software, Chinese Academy of Sciences, Beijing, China.
Shaochen MaDepartment of Neurology, Aerospace Center Hospital, Beijing, China.
Wei SunInstitute of Software, Chinese Academy of Sciences, Beijing, China.
Feng TianInstitute of Software, Chinese Academy of Sciences, Beijing, China.
Peifu WangDepartment of Neurology, Aerospace Center Hospital, Beijing, China.
Jilai LiDepartment of Neurology, Aerospace Center Hospital, Beijing, China.
Jichen DuDepartment of Neurology, Aerospace Center Hospital, Beijing, China.
Xingquan ZhaoDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhirong WanDepartment of Neurology, Aerospace Center Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Characteristic ocular symptoms are expected to serve as potential biomarkers for early diagnosis of Parkinson's disease (PD). However, possible ocular impairments in PD patients are rarely studied. The study aimed to investigate eye movement characteristics and pupil diameter changes in early-stage PD patients using virtual reality (VR)-based system and explore their contribution in the diagnosis of early-stage PD. Methods: Forty-three early-stage PD patients and 25 healthy controls were included. Eye movements and pupillary response of all subjects were recorded and evaluated by wearing VR glasses. All subjects completed pro-saccade and anti-saccade tasks. Saccadic eye movement and pupillary response parameters were analyzed. Random Forests method was used for classification task, the performance of the classification model in differentiating early-stage PD patients from healthy controls were evaluated. Results: PD patients exhibited reduced pro-saccade velocity and accuracy, longer average time to complete the pro-saccade, and lower anti-saccade error correction rate than healthy controls (all Conclusion: This study presents a non-invasive approach toward the diagnosis of early-stage PD with VR technology. Eye movement and pupillary response abnormalities measured using VR may be used as effective biomarkers for the diagnosis of early-stage PD.

Indexed as

diagnosiseye movementParkinson’s diseasepupillary responsevirtual reality

Identifiers

PMID40337168
PMCPMC12055775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.